News

Suraksha Diagnostic announced that the 21th Annual General Meeting(AGM) of the company will be held on 2 September 2026.

Suraksha Diagnostic announced that the Board of Directors of the Company at its meeting held on 21 May 2026, inter alia, have recommended the final dividend of Rs 0.5 per equity Share (i.e. 25%) , subject to the approval of the shareholders.

Net profit of Suraksha Diagnostic declined 15.02% to Rs 6.28 crore in the quarter ended March 2026 as against Rs 7.39 crore during the previous quarter ended March 2025. Sales rose 25.07% to Rs 81.41 crore in the quarter ended March 2026 as against Rs 65.09 crore during the previous quarter ended March 2025.For the full year,net profit rose 1.16% to Rs 32.19 crore in the year ended March 2026 as against Rs 31.82 crore during the previous year ended March 2025. Sales rose 23.13% to Rs 310.41 crore in the year ended March 2026 as against Rs 252.09 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales81.4165.09 25 310.41252.09 23 OPM %29.9229.47 -30.7332.23 - PBDT21.2417.94 18 86.0176.70 12 PBT9.989.21 8 44.5641.41 8 NP6.287.39 -15 32.1931.82 1 Powered by Capital Market - Live News

Suraksha Diagnostic will hold a meeting of the Board of Directors of the Company on 21 May 2026.

Net profit of Suraksha Diagnostic rose 22.28% to Rs 7.52 crore in the quarter ended December 2025 as against Rs 6.15 crore during the previous quarter ended December 2024. Sales rose 30.55% to Rs 77.69 crore in the quarter ended December 2025 as against Rs 59.51 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales77.6959.51 31 OPM %29.8130.68 - PBDT20.6216.87 22 PBT10.068.05 25 NP7.526.15 22 Powered by Capital Market - Live News